Disseminated Mycobacterium scrofulaceum infection has rarely been reported, and the majority of infections have been associated with AIDS or other immunocompromising diseases. We describe a previously healthy man with M. scrofulaceum infection whose clinical manifestations included miliary lung lesions, mediastinal lymphadenitis, granulomatous hepatitis, osteomyelitis, subcutaneous abscesses, and probable renal involvement. M. scrofulaceum was isolated from multiple specimens of sputum, urine, and the abscesses. The patient was treated successfully with the combination of isoniazid, ethambutol, rifampin, and ofloxacin. To our knowledge, this is the first detailed description of an extensively disseminated infection due to M. scrofulaceum in an immunocompetent host since the advent of AIDS.
anterior right chest wall. The patient denied having had diarrhea, vomiting, night sweats, or pyuria. He had previously been well and had no history of tuberculosis, drug or alcohol abuse, or known contact with persons who had tuberculosis. Findings on a chest roentgenogram obtained 6 months before admission were normal.
Physical examination revealed a temperature of37.6°C. The patient was alert and coherent. Fine bilateral crackles in the upper lobes and diminished breath sounds in the left lung base were detected during auscultation. Diffuse tenderness and abdominal guarding were also noted. No hepatosplenomegaly was found. A warm, erythematous, tender area that measured 6 X 6 em was present on the upper aspect of the right anterior chest wall. Within this area, a fluctuant 4 X 4-cm mass without central ulceration or purulent drainage was noted.
Laboratory studies revealed a hemoglobin concentration of 10.0 g/dL and a leukocyte count of 13, 200 figure  I) . A radionuclide bone scan demonstrated intense focal uptake in the medial portion of the right second rib.
On the second hospital day, the patient underwent needle aspiration ofthe chest mass. Ziehl-Neelsen staining ofthe puru-em 1996;22 (January) effusions (two samples), the ascitic fluid (one sample), stool (three samples), and liver biopsy tissue (one sample) were all negative. Susceptibility testing of the isolate was not done.
The patient described herein had clinical manifestations of M. scrofulaceum infection that included miliary lung lesions, mediastinal lymphadenitis, granulomatous hepatitis, osteomyelitis, subcutaneous abscesses, and probable renal involvement. The diagnosis of disseminated M scrofulaceum infection was based on the fact that the organism was cultured in specimens (sputum, urine, and abscess aspirate) from three anatomic sites. In addition, the isolate was identified by two independent laboratories, and its identity was confirmed by the characteristic findings on chromatographic fatty acid analysis.
Disseminated M scrofulaceum infection is an acknowledged rarity [5] [6] [7] [8] [9] . In 1979, Wolinsky reviewed 78 cases of disseminated disease caused by nontuberculous mycobacteria [2] in which scotochromogens (most of the isolates were presumptively identified as M scrofulaceum) accounted for 12.8% of all isolates. With respect to patients with AIDS, disseminated diseases due to Mycobacterium avium complex, Mycobacterium kansasii, and Mycobacterium haemophilum have caused great concern [10] [11] [12] ; however, M scrofulaceum infection in such patients is distinctly rare [5] . A review of the literature from May 1968 to March 1995 revealed only 11 documented cases of disseminated disease [5] [6] [7] [8] [9] ; ofthese, four were associated with AIDS. Two patients had no obvious underlying im-
lent aspirate revealed numerous acid-fast organisms. Oral antituberculous treatment with isoniazid (300 mg/d), ethambutol (1,200 mg/d), and rifampin (600 mg/d) was started. The pleural effusions and ascites were exudative, but no acid-fast bacilli were found. Microscopic examination of specimens of sputum (three samples), urine (two samples), and gastric lavage fluid (one sample) revealed acid-fast bacilli. Examination of a liver biopsy specimen showed granulomatous inflammation without caseous necrosis; Ziehl-Neelsen staining of the specimen was negative. A tuberculin test with use of 5 TV of PPD yielded an induration of 8 mm 72 hours after injection.
After 3 weeks, the patient's abdominal pain and dyspnea gradually disappeared. The infiltrates and miliary lesions in the lungs started to decrease in size, and the pleural effusions disappeared. The amount of ascites diminished dramatically. The cutaneous lesion over the upper aspect of the anterior right chest wall resolved. However, the patient continued to have intermittent fevers. After 7 weeks, the patient's condition improved significantly, but the fever had not abated. Ofloxacin (600 mg/d) was added to his regimen. Five days later, the fever subsided. Follow-up microscopic examinations and mycobacterial cultures of specimens of sputum and urine were negative. His clinical symptoms did not recur. Treatment was continued for 12 months after diagnosis.
Mycobacterial cultures (Middlebrook 7H9 media) of the aspirate, sputum (three samples), and urine (two samples) yielded acid-fast bacilli in 10, 12, and 16 days, respectively. Smooth orange colonies grew in the dark at 37°C on a LowensteinJensen slant, and these colonies intensified in color after exposure to light. The organism was identified as M scrofulaceum, since it produced urease and did not reduce nitrate or hydrolyze Tween 80 and had a characteristic fatty-acid profile (figure 2). Mycobacterial cultures of blood (two samples), the pleural Figure 1 . CTscanof the chestof a patientwithdisseminated Mycobacterium scrofulaceum infection shows confluent lymphadenopathy with prominent necrosis in the anteriormediastinum. Invasion of the contiguous chest wall with subcutaneous abscess formation was also apparent.
munodeficiency, although their HIV status was not known [6, 7] . The common clinical manifestations of these cases were recurrent skin lesions and granulomatous hepatitis [5] [6] [7] [8] [9] . Two patients had pulmonary infiltrates and cavitary lung disease, but none had miliary involvement. All of these patients, except for one with advanced systemic amyloidosis whose specimens of skin lesions, lymph nodes, liver, testis, epididymis, sputum, and urine were all positive for M. scrofulaceum, had positive cultures from less than three anatomic sites [5] [6] [7] [8] [9] .
The standard treatment regimen for disseminated infection due to M scrofulaceum is controversial, and the response to treatment is difficult to evaluate because of the rarity of this infection and the severity of the underlying diseases [5, 10, 11] . Ofloxacin has in vitro and in vivo activity against Mycobacterium tuberculosis, Mycobacterium fortuitum, and Mycobacterium chelonae [13, 14] . However, the use of ofloxacin in the treatment of M scrofulaceum infection has not been reported. Our patient's clinical response after the addition of ofloxacin to the treatment regimen was significant. Nevertheless, the use of ofloxacin to treat disseminated M. scrofulaceum infections needs further evaluation.
Because of the unusual clinical features of our case, it is of interest for three reasons. First, the extent of dissemination, which involved the lymph nodes, lungs, liver, bone, soft tissue, and, in all likelihood, the kidneys, is clinically impressive. Second, the fact that this disseminated disease occurred in a previously healthy person who was not infected with HIV is unusual. Third, the successful use of a combination of conventional antituberculous drugs as well as ofloxacin is remarkable. The patient's immunologic status may have contributed to the good clinical outcome.
In conclusion, this case demonstrates that M. scrofulaceum should be included in the differential diagnosis of disseminated mycobacterial infections in immunocompromised as well as immunocompetent hosts.
